openPR Logo
Press release

Disease - Modifying Agents Market New Innovations, Business Analysis, Shares and Forecast till 2031 | Biogen Inc., Merck KGaA, Elan Pharma India Pvt Ltd.

06-02-2021 05:08 PM CET | Health & Medicine

Press release from: Fact.MR

Disease - Modifying Agents market research study provides a crucial information of important participants, such as suppliers, manufacturers, distributors, traders, consumers, investors, etc.

Disease - Modifying Agents market study depicts an in-depth analysis on the current status of Disease - Modifying Agents market that consists of important types, and end uses.

To get in-depth information view the report - https://www.factmr.com/report/disease-modifying-agents-market

The data type of the Disease - Modifying Agents market study contains market revenue, import, export, progress rate, consumption, etc.

Further, the study focuses on the prominent and emerging regional and global trends contributing to the growth of Disease - Modifying Agents Market over the stipulated timeframe.

Request a Sample Report containing crucial Graphs and Figures – https://www.factmr.com/connectus/sample?flag=S&rep_id=5695

Key Segments of Disease-Modifying Agents Market Covered in the Report

Based on drug class, the global Disease-Modifying Agents market has been segmented as

Interferon Beta-1α/β

Natalizumab
Mitoxantrone
Glatiramer Acetate
Fingolimod
Dimethyl Fumarate
Ocrelizumab
Teriflunomide
Ciclosporin
Cyclophosphamide
Hydroxychloroquine
Leflunomide
Methotrexate
Mycophenolate
Sulfasalazine
Others

Based on Indication, the global Disease-Modifying Agents market has been segmented as

Multiple Sclerosis
Rheumatoid Arthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Systemic Sclerosis
Cancer
Others

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5695

Key findings of the Disease - Modifying Agents market report:

To investigate the competitive landscape – product launches, expansions, collaborations and acquisitions in the Disease - Modifying Agents market.
To analyze and research the global Disease - Modifying Agents landscape and growth outlook, which includes, revenue, production, consumption, historical and forecast.
To recognize important drivers, restraints, opportunities, and threats (DROT Analysis).


Get access to Table of Content covering 200+ Topics – https://www.factmr.com/connectus/sample?flag=T&rep_id=5695

The Disease - Modifying Agents market report answers the following queries:

What are opportunities and threats confronted by the players of the Disease - Modifying Agents market?
What are the trends influencing the global Disease - Modifying Agents market?
What are the alternatives and technologies used by vendors to mitigate development risk?


Pre-Book Right Now for Exclusive Discount– https://www.factmr.com/checkout/5695/S

Why choose Fact.MR?

With a multi-disciplinary approach, Fact.MR offers customized market research solutions to its clients.

Our analysts interact with trustworthy sources for information regarding the trends, and future prospects of various industries.

Fact.MR keeps pace with ongoing changes in the competitive scenario to serve insights to the clients in real time.

We carry pride in presenting the fact that our organization is recognized globally.

Read More Trending and Similar Reports from Fact.MR – http://www.globenewswire.com/en/news-release/2019/08/16/1903143/0/en/Demand-for-Autologous-Fat-Grafting-Positively-Endorsed-by-Rising-Breast-Augmentation-Procedures-reports-Fact-MR.html

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website - https://www.factmr.com/
Research Insight - https://www.factmr.com/report/disease-modifying-agents-market

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Disease - Modifying Agents Market New Innovations, Business Analysis, Shares and Forecast till 2031 | Biogen Inc., Merck KGaA, Elan Pharma India Pvt Ltd. here

News-ID: 2296808 • Views:

More Releases from Fact.MR

Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CAGR at a 5.3%
Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CA …
The global Fine Blanking Tools Market is set for steady growth over the next decade, driven by rising demand for high-precision components, ongoing industrial automation, and surging requirements from automotive, electronics, and aerospace sectors. According to a recent forecast, the market is expected to grow from approximately USD 948.1 million in 2025 to USD 1,430.6 million by 2035, at a compound annual growth rate (CAGR) of about 4.2 % between
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; Akorn Inc; Hikma; Hameln Pharmaceutical; Accord; Others.
10-08-2025 | Health & Medicine
Fact.MR
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; …
The global benzodiazepine drugs market is projected to expand in the coming decade, driven by growing incidence of anxiety, insomnia, alcohol-withdrawal disorders, and advances in pharmaceutical formulations. According to a recent Fact.MR report, the market was valued at approximately USD 2.35 billion in 2022, and is expected to grow at a compound annual growth rate (CAGR) of 2.8% to reach USD 3.1 billion by 2032. Market Drivers & Outlook The demand for
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Advances in 2D, Cart-Based Systems & AI-Enabled Portability
10-08-2025 | Health & Medicine
Fact.MR
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Adva …
The global Ultrasound Systems Market is on a strong growth trajectory, projected to rise from USD 10.8 billion in 2025 to approximately USD 19.7 billion by 2035, expanding at a CAGR of 6.2% during the forecast period. This growth is fueled by the rising demand for non-invasive diagnostic imaging, the increasing prevalence of chronic diseases, expanding healthcare infrastructure, and continuous technological innovations such as AI integration and portable imaging systems. Key
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethicon US LLC, Cardica Inc., Smith & Nephew Plc, CONMED Corporation., Purple Surgical Inc., Dextera Surgical Inc, and Others.
10-08-2025 | Health & Medicine
Fact.MR
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethico …
The global Surgical Staplers Market is forecast to show strong growth over the next decade, nearly doubling in value as demand surges for efficient, reliable wound closure in advanced surgical procedures. According to the latest Fact.MR Surgical Staplers Market Size & Share Forecast Outlook 2025-2035 report, the market is expected to grow from USD 6.0 billion in 2025 to USD 12.5 billion by 2035, at a compound annual growth rate

All 5 Releases


More Releases for Disease

Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research. Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight: Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and